IFPMA Interview: Antimicrobial Resistance, Regulatory Systems High On Pharma Industry 2016 Agenda 17/02/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Priorities for the pharmaceutical industry in 2016 are antimicrobial resistance and the quest for new antibiotics, the strengthening of regulatory systems to facilitate access to drugs, and work on non-communicable diseases, such as diabetes and cancer, according to the head of an international pharmaceutical industry group.
Questions Over WIPO Statements At UN Secretary-General’s Panel On Access To Medicines 17/02/2016 by William New, Intellectual Property Watch 1 Comment The World Intellectual Property Organization, a specialized agency of the United Nations, was unique among Geneva-based UN agencies for offering views at both recent meetings of the UN High-Level Panel on Access to Medicines held in Geneva and New York this month. Now WIPO has come under criticism from public health advocates for the views it gave.
Russia’s Promising Combined Ebola Vaccine: Phase III Trials To Start In 2016 15/02/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Russian Health Minister Veronika Skvortsova said today that two “highly effective” vaccines against Ebola have been developed over the course of 15 months in Russia. The combined vaccine GamEvac-Combi was presented during a briefing, with the two scientists who developed it, who own the intellectual property rights on the vaccines in Russia.
UN Panel On Access To Medicines Extends Deadline For Contributions 15/02/2016 by Intellectual Property Watch 2 Comments The United Nations High-Level Panel on Access to Medicines has announced that the deadline for the submission of stakeholders’ contributions has been extended to 28 February 2016. The panel also lifted restrictions on the number of contributions authors can submit.
WHO Full Speed On Zika R&D, Two Candidate Vaccines Emerging; Funders, Journals Commit To Sharing Of Data 12/02/2016 by Catherine Saez, Intellectual Property Watch 2 Comments In an update on research and development against the Zika virus, the World Health Organization today said several companies are working on diagnostic tools, and two candidate vaccines are being considered. Discussions are ongoing with countries to encourage sharing of samples of the virus with the WHO, and leading organisations and scientific journals signed a declaration yesterday on the sharing of data for public health emergencies.
EU Regulation On Identifier For Medical Products Published 09/02/2016 by Intellectual Property Watch Leave a Comment An anti-counterfeiting regulation on a unique identifier for medical products to ensure their authenticity was published today in the European Union.
The Zika Virus Challenge: Mapping A Policy Path To Vaccine Development 08/02/2016 by Priti Patnaik for Intellectual Property Watch 1 Comment The lack of preparedness to counter the effects of Zika virus follows a familiar script – a virus known since 1947, but one that has no currently available vaccine or treatments, like many neglected tropical diseases. This case could be illustrative of the wider struggle to finance investments into neglected diseases, but may tell a different story given its rarity of occurrence. It also may demonstrate how the World Health Organization is re-emerging as the global leader on response to outbreaks.
Vision, Urgency Of UN High-Level Panel On Access To Medicines Begins To Take Shape 05/02/2016 by William New, Intellectual Property Watch 4 Comments NEW YORK — It came as a surprise to some when the United Nations Secretary General’s office announced in November the setting up of a high level panel to urgently address access to medicines and other health technologies. After all, UN agencies in Geneva, most notably the World Health Organization, have been working on these issues for years. Yesterday at the UN in New York, an event was held to explain some of the vision and urgency behind the setting up of the panel, which includes an expert committee of representatives of some 10 international organisations and others. It also includes an open online call for contributed ideas until 18 February, and two public hearings.
Special Feature: WHO Still On Trail Of New Financing For R&D For Poor Populations’ Medical Needs 04/02/2016 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment World Health Organization members are expected to meet this spring to assess progress and discuss potential solutions to the lack of financing for research and development for diseases affecting primarily developing countries. The WHO Executive Board last week discussed and noted a report by the WHO secretariat for the preparation of the open-ended meeting. The exact date of the meeting is not certain, according to WHO officials, but would likely be in March or April.
WHO Preps For 2018 UN Review Of Cardiovascular Diseases, Cancers, Respiratory Diseases, Diabetes 03/02/2016 by Jahan Harry Taubman-Rezakhanlou for Intellectual Property Watch Leave a Comment World Health Organization Director-General Margaret Chan submitted a report to last week’s Executive Board meeting detailing progress made in establishing a framework for the implementation of a global action plan for prevention and control of noncommunicable diseases (NCDs – like obesity, cancer, diabetes). The global action plan is to be officially implemented after the United Nations General Assembly comprehensive review of the prevention and control of NCDs in 2018, designed to eventually reduce premature mortality from NCDs by a third in 2030 in accordance with the health-related Sustainable Development Goals.